Inceptive Nucleics, Inc.

Palo Alto, CA · Founded 2021 · CIK 0001993343 · Biotech · Private

AI models for computational drug design that predict molecular structures and therapeutic candidates

inceptive.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$100M
1 Form D · Sep 2023
37 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$99,699,966
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2828AVATAR MEDICAL, LLC——
2829NEPHROGEN INC.——
2830JUNIPERO THERAPEUTICS, INC.——
2831Inceptive Nucleics, Inc.—$100M
2832Arena Pharmaceuticals—$187M
2833Prelude Therapeutics—$97M
2834Coriell Life Sciences, Inc.—$10M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 5 related persons
  • Diana AjuriaExecutive Officer
  • Kevin HeyriesExecutive Officer
  • Do Soon KimExecutive Officer
  • Vijay PandeDirector
  • Jakob UszkoreitDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.